Breast cancer care across CION centres in Hyderabad · ArogyaSri, CGHS & cashless insurance accepted · Call 1800 202 8726

Treatment options

Risk-reducing surgery vs intensive screening: choosing a path

If you carry a BRCA change, you can lower breast cancer risk with surgery or watch closely with yearly MRI and mammograms. Surgery prevents most cancers, while screening aims to find cancer early and keeps your breasts. This page compares both paths, their limits, and how many women use them at different stages.

Call 1800 202 8726

Speak to an oncologist

Book a consultation

Talk to a breast cancer specialist at a CION centre near you.

Free call back. Your details stay private.

MM
Medically reviewed by Dr. Muralidhar MuddusettyConsultant Surgical Oncologist · MBBS (AIIMS), MS (Surgery, AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating

The short answer

Should a BRCA carrier choose risk-reducing surgery or intensive screening?

If you carry a harmful BRCA1 or BRCA2 change, there are two main ways to manage your breast cancer risk, and both are recognised, reasonable choices. Risk-reducing mastectomy removes most breast tissue, so it prevents most breast cancers from developing in the first place. Intensive screening leaves your breasts in place but checks them closely, usually with a breast MRI every year, and mammograms from an age your team recommends, sometimes alternating every six months. Screening does not lower your chance of getting breast cancer. Its aim is to find any cancer early, when it is small and usually very treatable. The trade-off is clear. Surgery offers the greatest reduction in risk and ends routine breast scans, but it is a major, permanent operation that removes feeling in the breasts and the ability to breastfeed, with possible complications and further reconstruction surgery. Screening avoids surgery and keeps your breasts, but brings regular appointments, some false alarms, biopsies, anxiety while waiting for results, and a small chance that a cancer is found between scans or needs chemotherapy. Many women screen for some years, often while planning a family, and then consider surgery later. Others choose surgery early to stop living scan to scan. Neither path is wrong. The best choice depends on your gene, age, family history, life plans, health and how you personally weigh these trade-offs.

Surgery prevents most cancers

It offers the largest reduction in breast cancer risk.

Screening finds cancers early

It keeps your breasts but does not lower the chance of cancer starting.

You can change paths

Many women screen first and consider surgery later.

This page gives general information only. A high-risk clinic can help you weigh both paths.

The two paths

What each path involves in practice

Both paths need a plan and ongoing support from a high-risk team.

Screening: yearly MRI

A breast MRI with contrast dye, usually each year, is the most sensitive screening test for young BRCA carriers.

Screening: mammograms

Added from an age your team recommends, as dense young breasts make mammograms less clear.

Some teams avoid mammograms at very young ages because of radiation.

Surgery: the operation

Removal of both breasts, often keeping skin and nipples, usually with reconstruction or a flat closure.

Surgery: afterwards

Routine breast scans usually stop, but awareness continues.

Still important

  • Reporting chest changes
  • Ovarian cancer risk planning
  • Reconstruction follow-up

Side by side

Comparing surgery and screening

Question Surgery compared with screening
Chance of breast cancer developing Greatly lowered with surgery; unchanged with screening
If cancer does develop Rare after surgery; screening aims to find it early
Breastfeeding and breast feeling Lost after surgery; kept with screening
Ongoing appointments Fewer after recovery from surgery; regular visits with screening
Reversibility Surgery is permanent; screening can move to surgery later

Not sure whether this applies to you?

Ask an oncologist

Words you may hear

The vocabulary, in plain language

Enhanced surveillance
A more frequent and detailed screening plan for people at high risk.
Contrast-enhanced MRI
An MRI scan using a dye injected into a vein to show breast tissue more clearly.
False positive
A scan result that looks worrying but turns out not to be cancer.
Interval cancer
A cancer found between scheduled screening tests.
High-risk clinic
A service that plans screening, testing and prevention for people with inherited risk.
Risk-reducing medicine
Hormone-blocking tablets that may lower breast cancer risk in some women.

Talk to our team

Have a question about your situation?

Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.

Call 1800 202 8726 Helpline open 24/7

Request a call back

Share your number and a specialist's team will call you.

Free call back. Your details stay private.

Being straight with you

Honest realities about both paths

Each path has limits, and understanding them helps you choose with open eyes.

Screening cannot prevent cancer

Even with excellent screening, some women will be diagnosed and need treatment.

MRI access varies

Yearly breast MRI with specialist reporting is not available everywhere in India, and travel may be needed.

Surgery has lasting effects

Complications, loss of sensation and further operations are real possibilities.

BRCA1 and BRCA2 differ

BRCA1 cancers can grow faster and appear younger, which affects how well screening works.

What this page cannot tell you

It cannot choose for you. A high-risk clinic can explain how each path fits your gene, age and plans.

Living with screening

Making screening work well for you

If you choose screening, a few habits help you get the most from it.

Book scans at the right time

For women who menstruate, MRI is often timed early in the cycle for clearer images.

Use the same centre

Comparing new scans with earlier ones helps radiologists spot real changes.

Plan for callbacks

Extra views or biopsies are common, and most turn out not to be cancer.

Tell the team about pregnancy

MRI with contrast is usually avoided in pregnancy, so screening plans change during this time.

Get support for scan anxiety

Worry before results is common; counselling or peer support helps many women.

A combined approach

Using both paths at different stages of life

For many BRCA carriers, the choice is not surgery or screening forever, but which one fits now.

Screening while building a family

Many women screen through their twenties and thirties so they can have children and breastfeed.

Reconsidering surgery later

Once family plans are complete, some move to preventive surgery.

Planning the ovaries too

Removing the ovaries and tubes is often advised at a set age range, and sometimes timed with breast decisions.

Reviewing regularly

Revisit the plan when family news, a scan result or life changes alter how you feel.

Commonly believed

What people assume about surgery and screening for BRCA

Screening is the irresponsible choice.

Intensive screening is a recognised, reasonable option for BRCA carriers.

A mammogram alone is enough for young carriers.

MRI is usually needed, because mammograms are less clear in young, dense breasts.

Once you start screening, you cannot choose surgery.

You can move to surgery at any time.

Surgery means you never need any follow-up.

Chest awareness and ovarian risk planning are still important.

Questions we are asked

Common questions about preventive surgery and screening for BRCA carriers

At what age does screening usually start for BRCA carriers?

Many guidelines suggest yearly breast MRI from the mid to late twenties, with mammograms added from around thirty, though timing varies. It may start earlier if relatives were diagnosed very young. A high-risk clinic will set a schedule based on your gene and family history.

Does screening save lives like surgery does?

Screening aims to find cancers early, when treatment works well, and many carriers who screen do very well. Surgery prevents most cancers altogether. Some studies suggest surgery may offer a survival advantage for certain groups, particularly BRCA1 carriers, but the evidence continues to develop.

Is MRI safe to have every year?

MRI does not use radiation, so yearly scans do not add radiation exposure. The contrast dye is generally safe, though rare allergic reactions occur and kidney function may be checked. People with some metal implants or severe claustrophobia may need special arrangements.

What happens if screening finds something?

You may be called back for more images, an ultrasound or a biopsy. Most callbacks do not turn out to be cancer. If cancer is found, it is often at an early stage, and your team will discuss treatment, which may include surgery on both breasts because of your gene.

Can risk-reducing medicines help BRCA carriers?

Hormone-blocking tablets can lower breast cancer risk in some high-risk women. Their benefit may be greater for BRCA2 carriers, whose cancers are more often hormone-sensitive. They have side effects and are not suitable during pregnancy, so discuss them with your team.

Is screening harder with BRCA1?

BRCA1-related cancers can appear at younger ages and grow more quickly, so a cancer may occasionally be found between yearly scans. Some teams consider more frequent imaging. This is one reason some BRCA1 carriers lean towards surgery, though screening remains a valid choice.

Does screening continue during pregnancy?

Contrast MRI is usually avoided in pregnancy. Ultrasound may be used, and screening often restarts after breastfeeding ends. Tell your high-risk team when you are planning pregnancy so they can schedule a scan beforehand and adjust the plan.

How do I decide between the two?

Consider your gene, age, family history, plans for children, feelings about surgery and your experience of scans. Genetic counselling, meeting a breast surgeon and talking with women who chose each path can help. Take your time, as this decision is rarely urgent.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Where to find us

Our centres in and around Hyderabad

Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.

CION Ameerpet

Beside Blue Fox Hotel, Satyam Theatre Road

Begumpet SR Nagar Punjagutta
CION Kukatpally

Opposite Big Bazaar, Mumbai Highway

KPHB JNTU Bharat Nagar
CION L.B. Nagar

Anu Arcade, next to L.B. Nagar Metro station

Vanasthalipuram Nagole Hayathnagar
CION Tolichowki

Inside Premier Hospital, Khader Bagh Road

Mehdipatnam Attapur Rethibowli
CION Masab Tank

Mahavir Hospital, AC Guards, Lakdikapul

Lakdikapul Khairatabad Basheer Bagh
CION Banjara Hills

Road No. 12

Jubilee Hills Madhapur Film Nagar
CION Kompally

Suchitra Circle, NH-44

Suchitra Circle Alwal Dundigal
CION Balanagar

Balanagar Main Road

Balanagar Fatehnagar Moosapet
CION Siddipet

Lohith Sai Hospital, Shivaji Nagar

Gajwel Husnabad Dubbaka
CION Sangareddy

X Roads, Pothreddipalle

Narayankhed Zaheerabad Patancheru

Talk to our team

Speak to a breast cancer specialist

Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.

Call 1800 202 8726 Helpline open 24/7

Request a call back

Share your number and a specialist's team will call you.

Free call back. Your details stay private.

Sources

  1. National Cancer Institute — BRCA gene changes: cancer risk and genetic testing
  2. American Cancer Society — Breast cancer screening for women at high risk
  3. NHS — Breast screening for women at higher risk

This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.

Call 1800 202 8726Book a consultation
Explore more

Breast Cancer Topics

Browse our complete guide to breast cancer — types, symptoms, tests and treatments. Tap any topic to read more.

HER2-Targeted Therapy

Cost of a full year of HER2 therapy in India De-escalated HER2 treatment for small tumours What happens if your heart function drops during treatment? Ejection fraction monitoring on HER2 therapy HER2-low breast cancer HER2-positive and hormone-positive together The full HER2 treatment pathway How does pertuzumab work, and who is it for? How does trastuzumab emtansine work, and who is it for? How long will you be on pertuzumab? Is adding pertuzumab worth the extra cost? Missed a dose of pertuzumab? What to do Missed a dose of trastuzumab emtansine? What to do Neratinib as extended adjuvant HER2 therapy Pertuzumab, fertility, menopause and sexual health How much does pertuzumab actually help? The numbers explained Pertuzumab cost in India Diarrhoea and rash on pertuzumab Heart function monitoring on dual HER2 blockade Pertuzumab infusion day Medicines, foods and supplements to avoid on pertuzumab Tests and monitoring while you are on pertuzumab Pertuzumab myths Pertuzumab (Perjeta) for breast cancer Pertuzumab side effects Pertuzumab T-DM1 infusion day Liver enzyme rises and nerve changes on T-DM1 Low platelets and bleeding risk on T-DM1 T-DM1 myths T-DM1 vs continuing trastuzumab after residual disease Trastuzumab emtansine (T-DM1) after residual disease Trastuzumab biosimilars in India Trastuzumab emtansine, fertility, menopause and sexual health How much does trastuzumab emtansine actually help? The numbers explained Trastuzumab emtansine cost in India Medicines, foods and supplements to avoid on trastuzumab emtansine Trastuzumab emtansine side effects Trastuzumab emtansine (Kadcyla) for breast cancer Lapatinib and tucatinib Why exactly twelve months of trastuzumab?

Hormone Therapy Medicines

Anastrozole, fertility, menopause and sexual health How much does anastrozole actually help? The numbers explained Anastrozole cost in India Medicines, foods and supplements to avoid on anastrozole Cholesterol, bone density and long-term effects of anastrozole Tests and monitoring while you are on anastrozole Anastrozole myths Anastrozole side effects Anastrozole vs tamoxifen Anastrozole (Arimidex) for breast cancer Exemestane, fertility, menopause and sexual health How much does exemestane actually help? The numbers explained Exemestane cost in India Medicines, foods and supplements to avoid on exemestane Joint pain and fatigue on exemestane Tests and monitoring while you are on exemestane Exemestane myths Exemestane side effects Why exemestane is taken after food and its steroidal effects Exemestane (Aromasin) for breast cancer Fulvestrant, fertility, menopause and sexual health How much does fulvestrant actually help? The numbers explained Fulvestrant cost in India Injection site pain and reactions on fulvestrant The fulvestrant injection Medicines, foods and supplements to avoid on fulvestrant Tests and monitoring while you are on fulvestrant Fulvestrant myths Fulvestrant side effects Fulvestrant vs aromatase inhibitors in advanced disease Fulvestrant (Faslodex) for breast cancer How much does goserelin actually help? The numbers explained Bone loss and mood changes on ovarian suppression Goserelin cost in India The goserelin implant Medicines, foods and supplements to avoid on goserelin Sudden menopause symptoms from ovarian suppression Tests and monitoring while you are on goserelin Goserelin myths Goserelin side effects Goserelin injections vs surgical ovary removal Goserelin (Zoladex) for breast cancer Hot flushes, joint pain and fatigue on fulvestrant How does anastrozole work, and who is it for? How does exemestane work, and who is it for? How does fulvestrant work, and who is it for? How does goserelin work, and who is it for? How does letrozole work, and who is it for? Postmenopausal hormone-receptor-positive breast cancer How long will you be on anastrozole? How long will you be on exemestane? How long will you be on fulvestrant? How long will you be on goserelin? How long will you be on letrozole? Taking anastrozole Taking exemestane Taking letrozole Letrozole, fertility, menopause and sexual health How much does letrozole actually help? The numbers explained Bone thinning on letrozole Letrozole cost in India Medicines, foods and supplements to avoid on letrozole Joint pain and morning stiffness on letrozole Tests and monitoring while you are on letrozole Letrozole myths Letrozole side effects Letrozole vs anastrozole vs exemestane Letrozole (Femara) for breast cancer Missed a dose of anastrozole? What to do Missed a dose of exemestane? What to do Missed a dose of fulvestrant? What to do Missed a dose of goserelin? What to do Missed a dose of letrozole? What to do Exemestane after letrozole or anastrozole Will your periods and fertility return after stopping goserelin?

Targeted & Newer Medicines

Abemaciclib, fertility, menopause and sexual health How much does abemaciclib actually help? The numbers explained Abemaciclib cost in India Diarrhoea on abemaciclib Two years of abemaciclib after surgery Medicines, foods and supplements to avoid on abemaciclib Tests and monitoring while you are on abemaciclib Abemaciclib myths Abemaciclib side effects Abemaciclib vs other CDK4/6 inhibitors Abemaciclib (Verzenio) for breast cancer CDK4/6 inhibitors in early breast cancer after surgery Adjuvant olaparib after surgery for BRCA carriers Alpelisib, fertility, menopause and sexual health How much does alpelisib actually help? The numbers explained Alpelisib cost in India High blood sugar on alpelisib Medicines, foods and supplements to avoid on alpelisib Tests and monitoring while you are on alpelisib Alpelisib myths Alpelisib (Piqray) for breast cancer Rash and mouth sores on alpelisib Alpelisib side effects Alpelisib vs everolimus after endocrine therapy fails Alpelisib for PIK3CA-mutated breast cancer CDK4/6 inhibitors in breast cancer Everolimus in hormone-resistant breast cancer How does abemaciclib work, and who is it for? How does ribociclib work, and who is it for? How does sacituzumab govitecan work, and who is it for? How long will you be on alpelisib? How long will you be on ribociclib? How long will you be on sacituzumab govitecan? Taking abemaciclib Taking alpelisib Taking ribociclib Liquid biopsy in metastatic breast cancer Missed a dose of abemaciclib? What to do Missed a dose of alpelisib? What to do Missed a dose of ribociclib? What to do Missed a dose of sacituzumab govitecan? What to do Newer drugs Elacestrant and oral SERDs for ESR1-mutant disease PARP inhibitors for BRCA-mutated breast cancer Do you need a PIK3CA test before alpelisib? Ribociclib, fertility, menopause and sexual health How much does ribociclib actually help? The numbers explained Ribociclib cost in India ECG monitoring and QT prolongation on ribociclib Medicines, foods and supplements to avoid on ribociclib Low white cell counts on ribociclib Tests and monitoring while you are on ribociclib Ribociclib myths Ribociclib side effects Ribociclib (Kisqali) for breast cancer Sacituzumab govitecan, fertility, menopause and sexual health How much does sacituzumab govitecan actually help? The numbers explained Sacituzumab govitecan cost and availability in India Diarrhoea on sacituzumab govitecan and how it is managed Medicines, foods and supplements to avoid on sacituzumab govitecan Tests and monitoring while you are on sacituzumab govitecan Sacituzumab govitecan myths Low counts, fever risk and hair loss on sacituzumab govitecan Sacituzumab govitecan infusion days Sacituzumab govitecan side effects Sacituzumab govitecan for triple-negative breast cancer Sacituzumab govitecan vs standard chemotherapy in triple negative breast cancer How newer drugs are sequenced with older ones

Metastatic Breast Cancer

What comes after a CDK4/6 inhibitor stops working? Ascites and abdominal swelling in advanced breast cancer Is my back pain bone metastasis or something else? Bone marrow involvement in advanced breast cancer Bone metastases in breast cancer Brain metastases in breast cancer Tumour markers CA 15-3 and CEA in metastatic breast cancer Chest wall and local recurrence after mastectomy Clinical trials in metastatic breast cancer Cost of long-term metastatic breast cancer treatment in India Explaining metastatic breast cancer to family and friends First-line treatment for hormone-positive metastatic breast cancer Confusion, thirst and drowsiness Lines of treatment in metastatic breast cancer Liver metastases in breast cancer Living well with metastatic breast cancer for years Lung metastases and pleural effusion in breast cancer Malignant pleural effusion Metastatic breast cancer and pink-ribbon culture Prognosis in metastatic breast cancer Treatment sequence in metastatic HER2-positive breast cancer Treatment options in metastatic triple negative breast cancer Oligometastatic breast cancer Why receptors are re-tested on a metastatic biopsy Scan intervals and monitoring in metastatic disease Understanding scan reports in metastatic breast cancer Skin metastases and nodules on the chest Surgery and radiation in metastatic breast cancer Treatment holidays and breaks in metastatic breast cancer When do doctors switch treatment in metastatic disease? Where breast cancer spreads and what each site feels like Working and earning with metastatic breast cancer
Call now Book free consultation